<DOC>
	<DOCNO>NCT01342744</DOCNO>
	<brief_summary>The purpose study determine effect metformin cardiovascular risk factor postmenopausal woman metabolic syndrome .</brief_summary>
	<brief_title>Metformin Postmenopausal Women With Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Postmenopausal woman age 4560 year metabolic syndrome accord The American Heart Association The National Heart , Lung , Blood Institute Previous cardiovascular disease Contraindicated metformin : serum creatinine &gt; 1.4 mg/dL , liver disease , alcoholism , congestive heart failure , chronic hypoxic lung disease , prior history lactic acidosis Previous administration metformin , hypoglycemic drug , lipidlowering drug , sex steroid , antiplatelet drug within 3 month enrollment Fasting blood sugar ≥ 200 mg/dL HbA1c &gt; 8 % Serum triglyceride ≥500 mg/dL Abnormal EKG</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Cardiovascular risk factor</keyword>
</DOC>